Anew Cambridge biotech will be working on a treatment using stem cells that could let children and adults with Type 1 diabetes do something their bodies currently cannot: produce their own insulin, the hormone that keeps blood sugar levels in balance. Douglas Melton, Xander University Professor of Stem Cell and Regenerative Biology and co-chair of the Department of Stem Cell & Regenerative Biology, and Peng Yi, member of the faculty of medicine at Joslin Diabetes Center, are mentioned. George King, professor of medicine at Joslin Diabetes Center, is quoted.
News & Research
